lactic acid has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooke, NJ; Greenstone, M; Home, PD; Kruszynska, YT | 1 |
| Hirvonen, J; Hyvönen, S; Karjalainen, M; Peltonen, L | 1 |
| Helle, A; Hirsjärvi, S; Hirvonen, J; Peltonen, L; Wiedmer, SK | 1 |
| Acerbi, D; Borrill, Z; Meuleners, L; Piccinno, A; Poli, G; Singh, D; Woodcock, A | 1 |
| Burrows, JL; French, E; Learoyd, TP; Seville, PC | 1 |
| Helle, A; Hirsjärvi, S; Hirvonen, J; Hyötyläinen, T; Peltonen, L; Wiedmer, SK | 1 |
1 trial(s) available for lactic acid and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Blood Glucose; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Electrocardiography; Ethanolamines; Female; Formoterol Fumarate; Half-Life; Heart Function Tests; Heart Rate; Humans; Lactic Acid; Male; Middle Aged; Potassium | 2008 |
5 other study(ies) available for lactic acid and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.
Topics: Administration, Inhalation; Adult; Beclomethasone; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Female; Glycerol; Humans; Insulin; Lactates; Lactic Acid; Lipid Metabolism; Male; Pyruvates; Pyruvic Acid; Reference Values | 1987 |
Effect of nanoprecipitation on the physicochemical properties of low molecular weight poly(L-lactic acid) nanoparticles loaded with salbutamol sulphate and beclomethasone dipropionate.
Topics: Albuterol; Beclomethasone; Calorimetry, Differential Scanning; Chemical Precipitation; Lactic Acid; Molecular Weight; Nanostructures; Particle Size; Polyesters; Polymers; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2005 |
Quantitative determination of drug encapsulation in poly(lactic acid) nanoparticles by capillary electrophoresis.
Topics: Albuterol; Beclomethasone; Cromolyn Sodium; Drug Carriers; Electrophoresis, Capillary; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Pharmaceutical Preparations; Polyesters; Polymers | 2008 |
Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Beclomethasone; Chitosan; Delayed-Action Preparations; Emulsions; Lactic Acid; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility | 2010 |
Novel, dynamic on-line analytical separation system for dissolution of drugs from poly(lactic acid) nanoparticles.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Beclomethasone; Chromatography, Liquid; Drug Carriers; Indomethacin; Lactic Acid; Nanoparticles; Polyesters; Polymers; Solubility; Solvents; Temperature | 2010 |